Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The gut microbiota is reportedly altered in patients with Type 2 Diabetes Mellitus (T2DM) (1)
NCT01944904 - Xylooligosaccharides (XOS) vs Placebo & Pre-Diabetic Condition is a randomized clinical prevention trial studying 2 g/day Xylooligosaccharides (XOS) or placebo in 29 randomized subjects with Pre-Diabetic Condition (1)
The Effects of Xyloologosarcharide (XOS) on colonic flora in volunteers with abnormal glucose levels
In our study, we identified 40 bacterial taxa associated with Pre-Diabetes (Pre-DM). Notably, the genera Enterorhabdus, [Howardella](brain://iyOXfS3u…